Shares of Mankind Pharma on Tuesday fell up to 3.2% to the day’s low of Rs 2,141.50 on BSE after PE investors likely sold 3.2% equity in the company or about 1.3 crore shares in block deals worth around Rs 2,700 crore. PE firm ChrysCapital’s affiliate entity Beige Ltd was reported to have issued a … Read more
Mankind Pharma, a recent entrant to the stock exchanges, has been included in several Nifty indices, including Nifty500, Nifty Midcap150, Nifty Midcap100 and Nifty200. The decision was taken at a meeting of the index maintenance sub-committee. Mankind Pharma, whose IPO was one of the largest this year, made a healthy debut on the exchanges in … Read more
Kotak Institutional Equities initiated coverage on Mankind Pharma stock with ‘Add’ rating for a price target of Rs 1,875. The domestic brokerage sees an 11% upside in the counter from current levels. “Mankind Pharma is well-positioned to further leverage its robust marketing prowess and reach. Within branded Rx, we expect a ramp-up of specialty and … Read more
Shares of Mankind Pharma will hit the Street on May 9 and grey market trends indicate a healthy listing for the company. According to market sources, the shares of Mankind Pharma are commanding a premium of Rs 120 apiece. Considering the upper price band of Rs 1,080, the company’s shares are expected to list a … Read more